18314253

Peregrin-Alvarez I

2008

Polycystic ovarian syndrome in a woman with polycystic kidney disease.

18317444

Kwiterovich PO

2008

Primary and secondary disorders of lipid metabolism in pediatrics.

18320864

Binder H

2007

Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.

18320865

LaZovic G

2007

Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients.

18321486

Zain MM

2009

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial.

18321495

Vlaisavljevi? V

2009

Impact of insulin resistance on the developmental potential of immature oocytes retrieved from human chorionic gonadotropin-primed women with polycystic ovary syndrome undergoing in vitro maturation.

18321516

Lindholm A

2008

Prevalence of symptoms associated with polycystic ovary syndrome.

18322300

Jensterle M

2008

Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.

18325506

Onalan R

2009

Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization.

18325508

Hsu MI

2009

Inappropriate gonadotropin secretion in polycystic ovary syndrome.

18325512

Castillo-Quan JI

2008

Insulin resistance, hypercortisolism, polycystic ovarian syndrome, and depression--nonrandom associations?

18331254

Vujovic S

2009

Transsexualism in Serbia: a twenty-year follow-up study.

18331737

Katcher HI

2009

Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome.

18332089

Goodarzi MO

2008

Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome.

18332151

Sam S

2008

Metabolic phenotype in the brothers of women with polycystic ovary syndrome.

18332896

Yildiz BO

2008

Assessment, diagnosis and treatment of a patient with hirsutism.

18334179

Tosca L

2008

[AMPK: a link between metabolism and reproduction?].

18334581

Lawson MA

2008

Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women.

18335328

Genazzani AD

2008

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.

18335331

Fanta M

2008

Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women.

18335395

Olszanecka-Glinianowicz M

2008

The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.

18339252

Palomba S

2008

Outlook: metformin use in infertile patients with polycystic ovary syndrome: an evidence-based overview.

18339256

Esinler I

2008

CYP1A1 gene polymorphism and polycystic ovary syndrome.

18339386

Kassi EN

2008

Correlates between hyperinsulinism and hyperandrogenemia?

18340677

Thiboutot DM

2008

Improving outcomes through collaboration.

18342858

Badawy A

2009

Ultrasound-guided transvaginal ovarian needle drilling (UTND) for treatment of polycystic ovary syndrome: a randomized controlled trial.

18345521

Moraloglu O

2008

Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients.

18346370

Zhao SY

2008

[Preliminary study of protein expression profiling of PCOS on different state].

18348172

Matchock RL

2008

Low digit ratio (2D:4D) is associated with delayed menarche.

18348723

Brannian JD

2008

Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice.

18350479

Erdo?an M

2008

Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.

18353318

DuQuesnay R

2009

Infertile women with isolated polycystic ovaries are deficient in endometrial expression of osteopontin but not alphavbeta3 integrin during the implantation window.

18355776

Kauffman RP

2008

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.

18357353

Villarroel AC

2007

[Polycystic ovary syndrome and pregnancy: clinical experience].

18357803

Palep-Singh M

2008

Ethnic variations in the distribution of obesity and biochemical metabolic abnormalities in fertility clinic attendees.

18357959

Zhang ZG

2007

Human umbilical cord blood serum in culture medium on oocyte maturation In vitro.

18359783

Cheung LP

2008

Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.

18362298

Barber TM

2008

Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.

18362299

M?hlig M

2008

Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.

18362300

Diamanti-Kandarakis E

2008

Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?

18362511

Falhammar H

2008

A 31-year-old woman with infertility and polycystic ovaries diagnosed with non-classic congenital adrenal hyperplasia due to a novel CYP21 mutation.

18363886

Diamanti-Kandarakis E

2008

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).

18364375

Vantyghem MC

2008

Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.

18364705

Dunaif A

2008

Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal.

18365851

Fenton A

2008

Management of polycystic ovary syndrome in postmenopausal women: a medical black hole.

18370651

Sundararaman PG

2003

Risk of atherosclerosis in women with polycystic ovary syndrome: a study from South India.

18370676

Beeson M

2004

Defective Activation of Protein Kinase C-z in Muscle by Insulin and Phosphatidylinositol-3,4,5,-(PO(4))(3) in Obesity and Polycystic Ovary Syndrome.

18370686

Misra S

2004

Effect of metformin in asian Indian women with polycystic ovarian syndrome.

18370740

Sridhar GR

2006

Association of Polycystic Ovary Syndrome with Anticonvulsant Use: ACase Report.

18370758

Tarkun I

2006

Association between Circulating Tumor Necrosis Factor-Alpha, Interleukin-6, and Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome.

18375410

Luque-Ram?rez M

2008

Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.

18375421

Kowalska I

2008

Insulin resistance is associated with decreased circulating mannan-binding lectin concentrations in women with polycystic ovary syndrome.

18375437

Tan BK

2008

Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.

18375940

Baillargeon JP

2008

Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism.

18376105

Francou M

2008

Characterization of pituitary cell populations in rats with induced polycystic ovaries.

18377903

Tu?rul S

2008

Clinical, endocrine, and metabolic effects of acarbose, a alpha-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome.

18378061

Chen X

2008

Prevalence of polycystic ovary syndrome in unselected women from southern China.

18378560

Fenkci SM

2008

Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.

18378757

Creanga AA

2008

Use of metformin in polycystic ovary syndrome: a meta-analysis.

18379937

Myers TD

2008

Bilateral anterior uveitis associated with clomiphene citrate.

18382816

Kumar HK

2008

Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovarian syndrome.

18382906

Thomann R

2008

Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.

18382909

Gregoriou O

2008

Treatment of hirsutism with combined pill containing drospirenone.

18385259

ESHRE Capri Workshop Group.

2008

Genetic aspects of female reproduction.

18385445

Abbott DH

2008

Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys.

18386674

Martin-Du Pan RC

2008

[Metabolic syndrome: jumble syndrome of obesity or specific entity? Which treatment: diet or polypill?].

18388196

Manner?s L

2008

Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.

18389188

Karakurt F

2008

Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.

18390799

Hutchison SK

2008

Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.

18390812

Guzick DS

2008

Do cardiovascular risk factors in polycystic ovarian syndrome result in more cardiovascular events?

18393042

Rajput R

2008

Ovarian hyperthecosis and response to antiandrogens: An uncommon presentation of a common disorder.

18393129

Karadeniz M

2008

Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.

18394616

Segal S

2009

Premature luteinization and in vitro fertilization outcome in gonadotropin/gonadotropin-releasing hormone antagonist cycles in women with polycystic ovary syndrome.

18400637

Da?delen S

2008

[Global confusion on the diagnostic criteria for metabolic syndrome: what is the point that guidelines can not agree?].

18402944

Glintborg D

2009

A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome.

18404823

Ardaens Y

2007

[The ovary: folliculogenesis and ovulation disorders].

18406239

Auchus RJ

1998

The regulation of human P450c17 activity: relationship to premature adrenarche, insulin resistance and the polycystic ovary syndrome.

18406240

Franks S

1998

Current developments in the molecular genetics of the polycystic ovary syndrome.

18406241

Kahsar-Miller M

1998

The development of the polycystic ovary syndrome: family history as a risk factor.

18406242

Apter D

1998

Endocrine and metabolic abnormalities in adolescents with a PCOS-like condition: consequences for adult reproduction.

18406243

Abbott DH

1998

Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys.

18406244

Dewailly D

1998

Markers of abdominal adipose tissue in women: relationship to ovarian function.

18406245

Ib??ez L

1998

Insulin resistance, premature adrenarche, and a risk of the Polycystic Ovary Syndrome (PCOS).

18406246

DiMartino-Nardi J

1998

Insulin resistance in prepubertal African-American and Hispanic girls with premature adrenarche: a risk factor for polycystic ovary syndrome.

18406758

Diamanti-Kandarakis E

1996

New perspectives in polycystic ovary syndrome.

18406807

Hsu SY

1997

Hormonal regulation of apoptosis an ovarian perspective.

18410553

Sathyapalan T

2008

A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.

18411091

Franks S

1989

Polycystic ovary syndrome.

18411171

Ehrmann DA

1991

Gonadotropin-releasing hormone agonist testing of pituitary-gonadal function.

18412786

Bhattacharya SM

2008

Abnormal glucose tolerance in polycystic ovary syndrome.

18413029

Quilliam S

2008

Uncertain infertility: three women's experiences.

18417315

Bruckert E

2008

[Abdominal obesity: a health threat].

18418429

Macut D

2008

Lipid and lipoprotein profile in women with polycystic ovary syndrome.

18421022

Chakrabarty S

2008

Peripubertal hyperinsulinemia upregulates phosphatidylinositol 3-kinase/akt pathway in rat ovaries.

18422468

Rizos CV

2008

Pleiotropic effects of thiazolidinediones.

18423625

Ota H

2008

Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome.

18423626

Tsigkou A

2008

High serum concentration of total inhibin in polycystic ovary syndrome.

18426742

Doi SA

2008

LDL species heterogeneity in the atherogenic dyslipidemia of polycystic ovary syndrome.

18426831

Cupisti S

2008

Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.

18429491

Tsigkou A

2008

Inhibins as diagnostic markers in human reproduction.